Actively Recruiting
The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation
Led by University of Social Sciences and Humanities, Warsaw · Updated on 2024-05-16
192
Participants Needed
1
Research Sites
108 weeks
Total Duration
On this page
Sponsors
U
University of Social Sciences and Humanities, Warsaw
Lead Sponsor
N
National Science Centre, Poland
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trial aimed to test internet-based Acceptance and Commitment Therapy (ACT) intervention to induce a meaning-making process in cancer patients following hematopoietic cell transplantation (HCT). ACT includes identifying personal values and engaging in activities consistent with these values, developing acceptance, as well as focusing on the present moment or performing activities with greater awareness. In total, 192 patients following the first (autologous or allogeneic) HCT will be randomly assigned in equal numbers to either the ACT intervention or an education session. Participants in both conditions will take part in 14-day training (about 5-10 minutes a day). The outcomes will be measured at baseline, during the intervention, immediately, 1 month, and 3 months after the intervention. Moreover, 6-9 additional participants will be randomly assigned to pre-intervention measurement length (1-3 weeks) before completing ACT intervention, followed by 7-day observations at the 2nd and 3rd post-intervention measure. The researchers hypothesized that ACT intervention would foster a meaning-making process and thus reduce distress induced by the discrepancy between global and situational meaning as compared to education.
CONDITIONS
Official Title
The Effect of an Online ACT Intervention on Meaning-Making Process in Cancer Patients Following Hematopoietic Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Qualification for the first autologous or allogeneic hematopoietic cell transplantation due to blood cancers or solid tumors
- Age 18 years or older
- Signed written informed consent
- Ability to read and write in Polish
- Daily access to the Internet using a computer or mobile device
You will not qualify if you...
- Major psychiatric or cognitive disorder that prevents giving informed consent or participating
- Inability to cooperate or provide informed consent
- Hearing, vision, or movement impairments that prevent participation
- Currently participating in any form of psychotherapy
- No access to the Internet
- No access to a computer or mobile device
- Unable to use a computer, mobile device, or the Internet
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Department of Bone Marrow Transplantation and Oncohematology
Gliwice, Poland, 44-102
Actively Recruiting
Research Team
A
Aleksandra Kroemeke, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here